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Abstract
Cyclic monoterpenes are a group of phytochemicals with antinociceptive, local anesthetic, and
anti-inflammatory actions. Effects of cyclic monoterpenes including vanilin, pulegone, eugenole,
carvone, carvacrol, carveol, thymol, thymoquinone, menthone, and limonene were investigated on
the functional properties of the cloned a7 subunit of the human nicotinic acetylcholine receptor
expressed in Xenopus oocytes. Monoterpenes inhibited the a7 nicotinic acetylcholine receptor in
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the order carveol > thymoquinone > carvacrol > menthone > thymol > limonene > eugenole >
pulegone ≥ carvone ≥ vanilin. Among the monoterpenes, carveol showed the highest potency on
acetylcholine-induced responses, with IC50 of 8.3 µM. Carveol-induced inhibition was
independent of the membrane potential and could not be reversed by increasing the concentration
of acetylcholine. In line with functional experiments, docking studies indicated that cyclic
monoterpenes such as carveol may interact with an allosteric site located in the α7 transmembrane
domain. Our results indicate that cyclic monoterpenes inhibit the function of human α7 nicotinic
acetylcholine receptors, with varying potencies.

Keywords: Nicotinic acetylcholine receptor; Monoterpenes; Carveol; Xenopus oocyte
1. Introduction
Monoterpenes are a structurally diverse group of phytochemicals and are major constituents of
essential oils. They are widely used for medicinal purposes and as food additives (Koziol et al.,
2014). Monterpenes include acyclic compounds, such as myrcene and geraniol; cyclic
compounds, such as thymol and carvacrol; and bicyclic compounds such as borneol and
eucalyptol. In earlier studies, cyclic monoterpenes have been shown to exhibit significant
anti-inflammatory, anti-oxidant, analgesic, and anxiolytic effects (for reviews, Guimarães et al.,
2013; 2014; Koziol et al., 2014). However, molecular targets mediating these actions of cyclic
monoterpenes are largely unknown. In earlier studies, cyclic monoterpenes have been shown to
modulate the functional properties of various ion channels, including voltage-gated Na+ channels
(Haeseler et al., 2002; Gaudioso et al., 2012), K+ (Sensch et al., 2000), voltage-gated Ca2+
channels (Seo et al., 2013), transient-receptor potential channels (Parnas et al., 2009), 5-HT3
receptors (Ashoor et al., 2013; Lansdell et al., 2015) and GABAA receptors (Priestley et al., 2003;
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Kessler et al., 2013) (for reviews, de Araújo et al., 2011; Oz et al., 2015).
Nicotinic acetylcholine receptors (nAChRs) belong to the Cys-loop family of ligand-gated
ion channels and are located throughout the central and peripheral nervous system. Neuronal
nAChRs, such as the homomeric α7 subtype, are located on presynaptic terminals or at
extrasynaptic sites on soma and dendrites (for a review: Zoli et al., 2015). Moreover, these
receptors have been shown to be expressed in non-neuronal structures (Egea et al., 2015), and in
immune system cells (Matteoli and Boeckxstaens, 2013). The high Ca2+ permeability and
presynaptic location of α7 nAChRs suggest that these receptors exert an important modulatory
influence in the neurotransmitter release and cellular excitability of the nervous system. These
receptors have also been shown to play roles in inflammation, nociception, psychosis, and
Alzheimer disease (for reviews Oz et al., 2013; Umana et al., 2013; Hurst et al., 2014). The
objective of the present study was to examine the effects of cyclic monoterpenes such as carveol
on the electrophysiological properties of human a7 nAChRs expressed in Xenopus oocytes.
2. Material and methods
2.1. Recordings from oocytes
Female Xenopus laevis frogs were obtained from Xenopus Express (Haute-Loire, France)
and housed in a container filled with dechlorinated water at 19-21 °C. Frogs were exposed to
12/12-h light/dark cycle and fed with dry food pellets obtained from Xenopus Express. The
procedures used in the present study were in accordance with the ‘Guide for the care and use of
laboratory animals’, National Institutes of Health (Bethesda, MD) and approved by the
Institutional Animal Ethics Committee at the UAE University. Experimental procedures used in
the present study were described in detail previously (Oz et al., 2004; Singhal et al., 2007). Briefly,
oocytes were removed surgically under local tricaine (Sigma, St. Louis, MO) anesthesia (0.15%
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w/V). Oocytes were dissected manually in a solution containing (in mM): NaCl, 88; KCl, 1;
NaHCO3, 2.4; MgSO4, 0.8; HEPES, 10 (pH 7.5). Isolated oocytes were then stored for up to seven
days in modified Barth's solution (MBS) containing (in mM): NaCl, 88; KCl, 1; NaHCO3, 2.4;
Ca(NO3)2, 0.3; CaCl2, 0.9; MgSO4, 0.8; HEPES, 10 (pH 7.5), supplemented with sodium pyruvate,
2 mM, penicillin 10,000 IU/l, streptomycin, 10 mg/l, gentamicin, 50 mg/l, and theophylline, 0.5
mM. During experiments, oocytes were positioned in a recording chamber with a volume of 0.2
ml and superfused at a rate of 2-3 ml/min. The bathing solution contained (in mM): NaCl, 95; KCl,
2; CaCl2, 2; and HEPES 5 (pH 7.4). The cells were impaled with two glass microelectrodes (1-10
MȐ) filled with 3 M KCl. Throughout the experiments, the oocytes were voltage-clamped at a
holding potential of -70 mV using a GeneClamp-500 amplifier (Axon Instruments Inc.,
Burlingame, CA), and current responses were recorded digitally at 2 kHz (Gould Inc., Cleveland,
OH).
Drugs were applied by a glass pipette positioned about 2 mm from the oocyte. Bath
applications of the compounds were attained by directly adding to the superfusate. All chemicals
used in preparing the solutions were from Sigma-Aldrich (St. Louis, MO). All the monoterpenes
and α-bungarotoxin were obtained from Sigma (St. Louis, MO). Stock solutions (10 mM) of
monoterpenes used in this study were prepared in distilled water.
The cDNA clone of human α7-nicotinic acetylcholine receptor was kindly provided by Dr.
J. Lindstrom (University of Pennsylvania, PA). The cDNAs for human α4, β2, α3, and β4 subunits
were kindly provided Dr. Subunit combinations, α and β subunits were injected at 1:1 ratio.
Capped cRNA transcripts were synthesized in vitro using an mMESSAGE mMACHINE kit from
Ambion (Austin, TX) and analyzed on 1.2% formaldehyde agarose gel to check the size and the
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quality of the transcripts.
2.2. Radioligand binding studies
Radioligand binding studies were performed with [3H]-a- bungarotoxin (56.0 Ci/mmol; Quotient
Bioresearch (Radiochemicals) Ltd, Cardiff, UK), essentially as described previously (Barker et al.
2004). Binding experiments were performed on intact transiently transfected human kidney
(tsA201) cells in HBS buffer containing 0.5% BSA to reduce non-specific binding. Samples were
incubated with radioligand (10 nM [3H]-a- bungarotoxin) in a total volume of 150 ml for 2 hours
at room temperature. Competition studies were carried out using [3H]-a- bungarotoxin (10 nM)
and varying concentrations (0.003 nM to 100 mM) of competing ligands. Samples were assayed by
filtration onto Whatman GF/A filters pre-soaked in 0.5% polyethyleneimine, followed by rapid
washing with phosphate buffered saline using a Brandel cell harvester and levels of bound
radioligand were determined by scintillation counting, as described previously (Barker et al.
2004).

2.3. Docking studies:
An NMR structure of the human α7 nAChR transmembrane domain (PDB code 2MAW)
(Bondarenko et al., 2014) was used for docking calculations and analysis. Docking of vanillin (cid
:01609418), pulegone (cid :442495), eugenole (cid : 3314), carvone (cid : 439570), carvacrol (cid
: 10364), carveol (cid : 7438), thymol (cid : 6989), thymoquinone (cid : 10281), menthone (cid :
443159), limonene (cid :22311) to the structural model (Bondarenko et al., 2014) was made by the
Autodock Vina program (Trott et al., 2010). Ligands and receptor files were prepared based on
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the procedure described in Autodock Tools (ADT) (Morris et al., 2009) documentation. ADT
assigned polar hydrogens, united atom’s Kollman charges and solvation parameters. Prepared files
were saved in PDBQT format. Affinity grid maps of 20x20x20Å with spacing 0.375Å were added.
Grid center was designated x,y,z dimensions: -8.73,-11.56 and -20.68 which correspond to center
of side chain on Phe453. These coordinates correspond to recently identified binding site for
ketamine in the human a7 nAChR transmembrane domain (Bondarenko et al., 2014). Docking
calculations were performed using the Lamarckian genetic algorithm (LGA) (Morris et al., 1998)
.The pose with the lowest binding free energy was aligned with receptor for further analysis of
interactions.
2.4. Data analysis
Average values were calculated as the mean ± standard error of the mean (S.E.M.).
Statistical significance was analyzed using Student's t test or ANOVA as indicated.
Concentration-response curves were obtained by fitting the data to the logistic equation,
y = Emax/(1+[x/EC50]-n),
where x and y are concentration and response, respectively, Emax is the maximal response, EC50 is
the half-maximal concentration, and n is the slope factor (apparent Hill coefficient).
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3. Results
In uninjected oocytes (n=5), acetylcholine at the highest concentration used in this study
(10 mM), did not cause detectable currents. On the other hand, application of 100 μM
acetylcholine for 3 to 4 sec induced rapidly activated inward currents in oocytes injected with
cRNA transcribed from cDNA encoding the human nAChR α7 subunit. These
acetylcholine-induced inward currents were completely inhibited by 100 nM α-bungarotoxin
(n=9, data not shown), indicating that currents recorded in our experiments were mediated by the
activation of recombinant a7 nAChRs.
Effects of 10 cyclic monoterpenes (vanilin, pulegone, eugenole, carvone, carvacrol,
carveol, thymol, thymoquinone, menthone, and limonene) were investigated on the function of a7
nAChRs (Fig. 1). In these experiments, ACh concentration of 100 µM was chosen since ACh
(EC50 = 96 µM) at this concentration produces approximately 50 % of maximal response for a7
nAChRs (see Fig. 6). A comparison of the effects of monoterpenes (10 μM for 10 min application)
on ACh (100 µM)-induced currents is presented in Fig. 2. Vanilin, pulegone, eugenole, and
carvone (at 10 μM) did not cause a significant change in the amplitude of currents evoked by
acetylcholine (100 µM). However, all of the other monoterpenes compounds examined produced
significant inhibitory effects on a7 nAChRs (Fig. 2). The rank order of their inhibitory effects was:
carveol > thymoquinone > carvacrol > menthone > thymol > limonene. Increasing the application
time to 10 in to 20 min which is 6 fold more than τ1/2 for carveol (see Fig. 4A) did not cause any
further change on the effects of the monoterpenes (see supplement Fig. 1). Dose-response curves
for the compounds for monoterpenes that induced a significant inhibitory effect were shown in
supplement Fig. 2. None of the monoterpenes tested alone at 10 µM induced an agonist action on
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a7 nAChRs (n=4-6, for each compound). Recordings of the acetylcholine-induced currents, in the
absence and presence of 10 µM carveol and after 10 min recovery are shown in Fig. 3A, The
time-course of effects of carveol on the amplitude of acetylcholine-activated currents are shown in
Fig. 3B. Inhibition by carveol reached a steady-state level in less than 10 min and was fully
reversible within a washout period of 10 to 15 min. In the absence of carveol (control condition),
the maximal amplitude of acetylcholine-activated currents remained unaltered during the course
of the experiments (Fig. 3B, controls).
It is noteworthy that the effect of carveol on α7 nAChRs was dependent on the duration of
pre-application. For example, without carveol preincubation, the coapplication of carveol (10 μM)
and acetylcholine (100 μM) did not cause a significant alteration in the amplitude of maximal
current (0 time point in Fig. 4A). However, increasing the preincubation time of carveol caused
significantly enhanced inhibition, reaching a maximal level within 10 min (with a half-time (τ1/2)
of 3.4 ± 0.4 min; Fig. 4A). Since the magnitude of the carveol effect was time-dependent, an
application time of 10 min was used to ensure equilibrium conditions. Carveol inhibited the
function of a7 nAChRs in a concentration-dependent manner with IC50 and slope value of 8.3 ± 0.5
µM and 0.86, respectively (Fig. 4B).
We also investigated whether the inhibition of a7 nAChRs by carveol was affected by
changes in the membrane potential. Each tested potential was held for 30 sec and then returned to
-70 mV. As shown in Fig. 5A, the inhibition by carveol (10 µM) of currents evoked by
acetylcholine (100 µM) does not seem to be voltage-dependent. Examination of the
current-voltage relationship (Fig. 5B) shows that the extent of inhibition by carveol was not
altered significantly at different holding potentials (P>0.05, n=7, ANOVA).
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Activation of a7 nAChRs caused a significant increase in intracellular Ca2+ and activated
endogenous Ca2+-dependent Cl- channels in Xenopus oocytes (Sands et al., 1993). It was possible
that the effect of carveol was mediated by the inhibition of inward Cl- currents induced by Ca2+
entry. Thus, we tested whether inward Cl- currents contribute to the carveol-induced inhibition of
a7 nAChRs. For this reason, oocytes were injected with BAPTA (100 mM, 50 nL) to chelate
intracellular Ca2+ increases. In addition, extracellular Ca2+ was replaced with Ba2+, since Ba2+ can
pass through α7-nicotinic acetylcholine receptors but causes a significantly less activation of
Ca2+-dependent Cl- channels (Sands et al., 1993). Carveol (10 µM) produced the same level of
inhibition of a7 nAChRs (54 ± 5 in controls versus 49 ± 6 in Ba2+ containing solutions, ANOVA,
n=6-7, P>0.05; Fig. 5C). In agreement with these results, in control experiments, carveol at the
highest concentration used in this study (300 µM for 10 min) did not cause any change on the
magnitudes of holding-currents (43 ± 5 nA in control versus 46 ± 4 nA in carveol at -70 mV
holding potential) or input resistance (1.8 ± 0.3 MΩ in control versus 1.7 ± 0.4 MΩ in carveol;
n=9) of oocytes, indicating that intracellular Ca2+ levels were not altered by carveol.
Carveol may decrease the binding of acetylcholine to the a7-nAChR and inhibit these
receptors as a competitive antagonist. For this reason, the effect of carveol was examined at
different concentrations of acetylcholine. In Fig. 6, concentration-response curves for
acetylcholine were presented in the absence and presence of 30 µM carveol. In the presence of
carveol, the potency of acetylcholine was not altered significantly. However the maximal response
induced by acetylcholine decreased significantly (n=6-8). The respective EC50 values in the
absence and presence of carveol were 96 ± 11 μM and 87 ± 9 μM (P>0.05, ANOVA, n=6-9) and
slope values were 1.2 ± 0.3 and 0.9 ± 0.4, suggesting that carveol inhibits the nicotinic
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acetylcholine receptors in a non-competitive manner with respect to acetylcholine.
If carveol is, indeed, binding at a site other than the orthosteric agonist binding site, it
would not be expected to displace the binding of a competitive antagonist such as a-bungarotoxin.
To examine this, ability of carveol to displace the specific binding of [3H]-a-bungarotoxin was
examined in a transiently transfected mammalian cell line (tsA201) expressing human
recombinant a7 nAChRs. No significant displacement of [3H]-a-bungarotoxin was observed with
carveol, even at the highest concentrations tested (1 mM) (Fig. 7). In contrast, the competitive
antagonist methyllycaconitine (MLA) caused complete displacement of [3H]-a-bungarotoxin in a
dose-dependent manner, with an IC50 value of 33 ± 3 nM (n=5).
The effect of carveol on the functional properties of other neuronal nAChR subtypes was
also examined but did not show significant inhibitory or potentiating effects (Fig. 8).
Computer docking studies were conducted with a previously described NMR structure of
the a7 transmembrane domain (Bondarenko et al., 2014). The aim of these studies being to test the
hypothesis that monoterpines compounds might exert there inhibitory effect by binding to a site
similar to that previously identified for the non-competitive antagonist ketamine (Bondarenko et
al., 2014). The results of the docking studies (Fig. 9 and Table 1) support the conclusion that cyclic
monoterpenes such as carveol are able to interact with a similar transmembrane site to that
reported previously for ketamine (Bondarenko et al., 2014).
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4. Discussion
In this study, we provide evidence that cyclic monoterpenes inhibit human α7 nAChRs
with varying potencies. While vanilin, pulegone, eugenole, and carvone did not alter functional
properties of a7-nAChR, other monoterpenes inhibited the activity of this receptor in the rank
order: carveol > thymoquinone > carvacrol > menthone > thymol > limonene. The inhibitory effect
of carveol was reversible and concentration-dependent. Increases in the concentration of
acetylcholine did not significantly alter the inhibitory effect of carveol, suggesting that it acted
through a non-competitive mechanism of action. This conclusion was supported by competition
radioligand binding studies demonstrating that carveol was unable to displace the binding of the
competitive antagonist [3H]-a-bungarotoxin.
Many of the cyclic monoterpenes have been shown to release Ca2+ from intracellular stores
(for a review Oz et al., 2015). In Xenopus oocytes, activation of Ca2+-activated Cl- channels by
changes in intracellular Ca2+ levels (for reviews: Fraser and Djamgoz, 1992; Terhag et al., 2015)
can interfere with a7 nAChR-mediated currents. However, during our experiments, application of
carveol, even at the highest concentration (300 µM) used in this study, did not cause any alteration
on the holding currents, suggesting that carveol did not affect intracellular Ca2+ concentration. In
Xenopus oocytes, activation of a7 nAChRs, due to their high Ca2+ permeability, allows sufficient
Ca2+ entry to activate endogenous Ca2+-dependent Cl- channels (Séguéla et al., 1993; Sands et al.,
1993). However, in oocytes injected with BAPTA and recorded in solution containing 2 mM Ba2+,
carveol continued to inhibit a7 nAChR-mediated currents, suggesting that Ca2+-dependent Clchannels were not involved in carveol inhibition of nicotinic responses.
Open-channel blockade is a widely used model to describe the block of ligand-gated ion
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channels (Hille, 2001). However, this model does not seem to be consistent with the results
obtained in the present study. For an open channel blocker, the presence of the agonist is required
for the entrance of the blocker to the channel after the receptor-ion channel complex has
undergone an agonist-induced conformational change. In contrast to open channel blockers,
preincubation of carveol caused further inhibition (Fig. 4) indicating that the channel does not
need to be open in order to interact with carveol. Secondly, inhibition by carveol was not sensitive
to changes in membrane potential, suggesting that the binding site for carveol is not within the
transmembrane region.
In docking studies, our results show that pose of the ligand in the binding site is located in
the cavity of lower part of transmembrane domain, and that hydrophobic interactions in the
pocket between helices play an important role and can be correlated with % inhibition measured
in the experiment (Table 1). As can be seen in Fig. 9, the binding position of carvacrol and
thymoquinone is parallel to the ring of Phe453, and both ligands have favorable binding energies
with -6.3 kcal.mol and -6.7 kcal/mol, respectively. Interestingly, these two compounds have
demonstrated effective inhibition. In contrast, carvone, with binding energy of -6.2 kcal/mol, has
a monoterpene ring is not parallel but rotated relative to ring of Phe453. Notably, all other ligands
follow the same pattern and their behavior can be described similarly except limonene which has
binding position similar to thymoquinone and relatively favorable binding energy -6.1 kcal/mol
but demonstrates only 15 % of inhibition.
Moreover, factors other than effective binding position can also influence inhibition. For
example differences in hydrophobicity of the ligands may play a role in the favorable interaction
of ligands with the membrane and may prevent interaction with receptor. Monoterpenes are
highly lipophilic compounds with Log p values ranging between 2 and 5 (Turina et al., 2006;
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Zunino et al., 2011).
Analysis of binding interaction of ligands with residues of the binding was made . It was
noticed that favorable interaction of the ligands with residues in the binding site such as Ser285,
Leu248, Ile217 and Lys239 might be important in influencing inhibition. It is possible that the
specific conformation of the ligand inside of the binding site may prevent gating movement of
helix TM2. There is direct experimental evidence that the TM2 helix plays an important role in
movements associated with the gating of nAChRs, with the pore-lining TM2 helix changing
conformation during receptor activation (Unwin and Fujiyoshi, 2012). In closed conformation of
the receptor, when helix TM2 has a kinked orientation, the hydrophobic cavity between helices is
expected to have a larger volume, which may be favorable for the binding of receptor inhibitors.
It is possible that the binding of ligans such as monoterpenes to the closed conformation will
prevent the helix TM2 from adopting the straighter orientation that is characteristic of the open
channel.
Monoterpenes such as menthol have been shown to activate Transient Receptor Channel
Melastatin 8 (TRPM8) in the concentrations ranging from 10 µM to 1 mM (for reviews, de
Araújo et al., 2011; Oz et al., 2015). In addition to menthol, in the concentration range of 100 µM
to 10 mM, many other monoterpenes including menthone, geraniol, citronellal, eucalyptol,
linalool, carvone, isopulegol, and euganol activate TRPM8 receptors (McKemy et al., 2002;
Behrendt et al., 2004). However, these effects are not specific and actions of monoterpenes
extend to other members of TRP channel family (for reviews, de Araújo et al., 2011; Oz et al.,
2015).
In conclusion, our results demonstrate that cyclic monoterpenes directly inhibit the
function of human α7-nicotinic acetylcholine receptor, possibly by interacting with an allosteric
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transmembrane site.
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Figure legends
Fig. 1. Chemical structures of cyclic monoterpenes used in the present study.
Fig. 2. Relative potencies of cyclic monoterpenes tested on human α7 nicotinic acetylcholine
receptor. The effects of 10 µM of monoterpenes; vanilin, pulegone, eugenole, carvone, carvacrol,
carveol, thymol, thymoquinone, menthone, and limonene on acetylcholine (ACh; 100
µM)-induced currents. The effects of monoterpenes were tested after 10 min application of each
drug. Each bar represents the normalized mean ± S.E.M. Numbers of experiments are shown on
top of each bar. * indicate statistical significance at the level of P<0.05 using paired t-test (controls
in the same oocytes).
Fig. 3. Effects of carveol on α7-nicotinic acetylcholine receptor-mediated responses. (A) Records
of currents activated by acetylcholine (ACh; 100 μM) in control conditions (left), during
co-application of 10 μM carveol and acetylcholine after 10 min pretreatment with 10 μM carveol
(middle), and 15 min following carveol washout (right). (B) Time-course of the effect of carveol
(10 μM) on the maximal amplitude of the acetylcholine-activated currents. Each data point
represents the normalized mean ± S.E.M. of 6 to 8 experiments. Application time for carveol is
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shown by the horizontal bar in the figure.
Fig. 4. Time and concentration-dependent effects of carveol on α7- nicotinic acetylcholine
receptors. (A) Increasing the preapplication time of carveol (10 μM) enhances its inhibition of the
α7-receptor. Each data point represents the mean ± S.E.M. of 7 to 8 oocytes. (B) Inhibition of
α7-nicotinic acetylcholine receptor function by carveol is concentration-dependent. Each data
point represents the mean ± S.E.M. of 6 to 8 oocytes.
Fig. 5. Inhibition of acetylcholine-induced responses by carveol is not dependent on changes in
membrane potential. (A) Current-voltage relationships of acetylcholine-activated currents in the
absence and presence of carveol (10 μM). Currents induced by 100 μM acetylcholine before
(control,) and after 15 min treatment with carveol () were normalized and plotted in the graph.
Each data point presents the means ± S.E.M. of 6 to 8 experiments. (B) Inhibitory effect of carveol
is presented at different voltages. (C) α7-nicotinic acetylcholine receptor mediated currents in 2
mM Ca2+ containing MBS solution (control) or in 2 mM Ba2+ containing MBS solution. Bars
represent the means ± S.E.M. of 5 to 7 experiments.
Fig. 6. Concentration-response curves for acetylcholine-induced currents in control and in the
presence of carveol. Effects of carveol on the acetylcholine concentration-response relationship.
In control conditions current was activated by acetylcholine (1 μM to 3 mM). Subsequently, 30
µM carveol was applied for 10 min and acetylcholine induced responses were measured in the
presence of carveol. Currents activated by acetylcholine were normalized to the maximal response
under control conditions. Concentration-response curves were plotted by fitting the curves from
6 to 7 oocytes as described in the methods section. Data points obtained before (control) and after
10 min treatment with carveol (30 μM) were indicated by filled and open circles, respectively.
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Fig. 7. The effect of carveol on the specific binding of [3H]-a-bungarotoxin. Human α7-nicotinic
acetylcholine receptors expressed in transiently transfected human kidney (tsA201) cells were
incubated with the [3H]-a-bungarotoxin (10 nM). The competitive antagonist methylycaconitine
(MLA) displaced the binding of [3H]-a-bungarotoxin in a dose-dependent manner IC50 = 33 ± 3
nM (n=5). In contrast, no significant displacement of [3H]-a-bungarotoxin was observed with
carveol (n=3), even at the highest concentrations tested (1 mM). All points are means ± S.E.M
from 3-5 independent experiments.

Fig. 8. Comparison of the effect of 100 µM carveol on currents mediated by α7, α4β2, α3β4, α3β2,
and α4β4 subunits. Bars represent the means ± S.E.M. of 6 to 8 experiments.

Fig. 9. The results of docking calculations for cyclic monoterpenes obtained from their docking
into the human α7-nicotinic acetylcholine receptor transmembrane domain; A-C) position of
carvacrol (red), thymoquinone (blue), carvone (green), vanillin (pink), and D) interaction of
ligands with the residues of the binding site.
Supplementary Fig. 1. Inhibition of α7-nicotinic acetylcholine receptor mediated currents at 15
and 20 minutes of perfusion with monoterpenes. The extent of inhibition at 10 and 20 min was
shown in light and dark grey colors, respectively. Bars represent the means ± S.E.M. of 5 to 6
experiments.
Supplementary Fig. 2. Concentration-dependent inhibition of α7-nicotinic acetylcholine receptor
by monoterpenes. The IC50 values for carvacrol, thymol, thymoquinone, menthone, and limonene
are 12.8, 20.1, 4.4, 18.3, and 29.7 µM, respectively. Each data points represent the means ± S.E.M.
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of 5 to 7 experiments.
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Table 1. Percent inhibition, calculated binding energies and location of lowest energy pose.

Compound

Experimental
% inhibition

Calculated

Location lowest energy pose relative

binding energy,

to binding site of Ketamine

kcal/mol

(Bondarenko et al., 2014)

Vanillin

-14

-5.6

Not in a binding site

Pulegone

6

-6.0

Not in a binding site

Eugenol

9

-6.1

Not in a binding site

Carvone

1

-6.2

In a binding site

Carvacrol

39

-6.3

In a binding site

Carveol

57

-6.7

In a binding site

Thymol

26

-6.6

In a binding site

Thymoquinone

49

-6.8

In a binding site

Menthone

34

-6.7

In a binding site

Limonene

17

-6.1

In a binding site
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